Tachykinin receptors in the gut: Physiological and pathological implications

Current Opinion in Pharmacology

Volumn 1, Issue 6, 2001, Pages 583-590

  Holzer, Peter ^a   Holzer Petsche, Ulrike ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Gastrointestinal inflammation; Gastrointestinal motility; Gastrointestinal nociception; Gastrointestinal secretion; Neurokinin A; Neuroscience; Pharmacology; Physiology; Substance P; Tachykinin receptors; Vascular permeability

Indexed keywords

NEUROKININ 1 RECEPTOR; NEUROKININ 2 RECEPTOR; NEUROKININ 3 RECEPTOR; NEUROKININ A; RECEPTORS, NEUROKININ 1; RECEPTORS, NEUROKININ 2; RECEPTORS, NEUROKININ 3; SUBSTANCE P; TACHYKININ RECEPTOR;

ANIMAL; ENTERITIS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HUMAN; IRRITABLE COLON; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVIEW;

ANIMAL; COLONIC DISEASES, FUNCTIONAL; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL SYSTEM; HUMAN; INFLAMMATORY BOWEL DISEASES; NEUROKININ A; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROKININ-2; RECEPTORS, NEUROKININ-3; RECEPTORS, TACHYKININ; SUBSTANCE P; SUPPORT, NON-U.S. GOV'T;

EID: 0035656920     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(01)00100-X     Document Type: Review

References (67)

1. Hökfelt T., Pernow B., Wahren J. Substance P: a pioneer amongst neuropeptides. J Intern Med. 249:2001;27-40.
2. Holzer P., Holzer-Petsche U. Tachykinins in the gut. Part I. Expression, release and motor function. Pharmacol Ther. 73:1997;173-217.
3. Yunker A.M.R., Krause J.E., Roth K.A. Neurokinin B- and substance P-like immunoreactivity are co-localized in enteric nerves of rat ileum. Regul Pept. 80:1999;67-74.
4. 1 tachykinin receptor: evidence from quantitation of receptor endocytosis. Br J Pharmacol. 126:1999;131-136.
5. Spångéus A., Forsgren S., El-Salhy M. Effect of diabetic state on co-localization of substance P and serotonin in the gut in animal models. Histol Histopathol. 16:2001;393-398.
6. Holzer P., Holzer-Petsche U. Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammation. Pharmacol Ther. 73:1997;219-263.
7. Costa M., Brookes S.J.H., Hennig G.W. Anatomy and physiology of the enteric nervous system. Gut. 47:2000;iv15-iv19. A concise summary of the types of enteric neurones and their relevance to digestive function.
8. Furness J.B. Types of neurons in the enteric nervous system. J Auton Nerv Syst. 81:2000;87-96. A comprehensive overview of enteric neurone types, including those expressing tachykinins, and their functional implications in the gut.
9. Schemann M., Reiche D., Michel K. Enteric pathways in the stomach. Anat Rec. 262:2001;47-57. A comprehensive overview of the intrinsic neural pathways in the stomach and of the specialisations of the ENS in this region of the gut.
10. Lomax A.E., Furness J.B. Neurochemical classification of enteric neurons in the guinea-pig distal colon. Cell Tissue Res. 302:2000;59-72. The types of enteric neurones expressing tachykinins in the colon are found to be largely similar to those described in the small intestine.
11. 3 tachykinin receptor localization and tachykinin distribution in the ileum of the mouse. Anat Embryol. 202:2000;247-255. There are species-related differences in tachykinin receptor distribution between the intestine of mouse, rat and guinea pig.
12. Hens J., Vanderwinden J.M., De Laet M.H., Scheuermann D.W., Timmermans J.P. Morphological and neurochemical identification of enteric neurones with mucosal projections in the human small intestine. J Neurochem. 76:2001;464-471.
13. 1 receptors on lymphoid cells is increased in colitis ulcerosa and Crohn's disease, whereas that in the myenteric plexus is enhanced in Crohn's disease only.
14. 2 receptors being found primarily on inflammatory cells of the lamina propria.
15. Smith V.C., Sagot M.A., Wong H., Buchan A.M.J. Cellular expression of the neurokinin 1 receptor in the human antrum. J Auton Nerv Syst. 79:2000;165-172.
16. 1) receptor in relation to substance P innervation in rat duodenum after irradiation. Regul Pept. 98:2001;115-126.
17. 1 receptors are present in the longitudinal and circular muscle throughout the small and large intestine.
18. 2 tachykinin receptors and substance P in nerve endings of guinea-pig ileum. Neurosci Lett. 287:2000;71-75.
19. Mann P.T., Furness J.B., Southwell B.R. Choline acetyltransferase immunoreactivity of putative intrinsic primary afferent neurons in the rat ileum. Cell Tissue Res. 297:1999;241-248.
20. 3 tachykinin receptors in the guinea-pig ileum revealed by specific binding of fluorescently labelled agonists. Histochem Cell Biol. 112:1999;233-246.
21. Alex G., Kunze W.A.A., Furness J.B., Clerc N. Comparison of the effects of neurokinin-3 receptor blockade on two forms of slow synaptic transmission in myenteric AH neurons. Neuroscience. 104:2001;263-269.
22. Maggi C.A. Principles of tachykininergic co-transmission in the peripheral and enteric nervous system. Regul Pept. 93:2000;53-64.
23. Patacchini R., Maggi C.A., Holzer P. Tachykinin autoreceptors in the gut. Trends Pharmacol Sci. 21:2000;166.
24. 1 receptor-mediated inhibitory responses in the guinea-pig small intestine. Neuropeptides. 33:1999;91-97.
25. 1 receptor knockout mice. Am J Physiol. 277:1999;G1173-G1179.
26. 1 receptors on excitatory and inhibitory motor neurones in the small intestine and on inhibitory motor neurones in the colon.
27. 1 receptor agonists in the guinea-pig small intestine. Neurogastroenterol Motil. 12:2000;197-204.
28. 2 receptors can slow propulsive peristalsis by activating inhibitory enteric pathways that utilise nitric oxide as a transmitter.
29. 2 receptors in human intestine and urinary bladder. Eur J Pharmacol. 398:2000;389-397.
30. 3 receptor antagonist given singly inhibits peristalsis to an appreciable degree only after partial blockade of muscarinic or nicotinic acetylcholine receptors, combined blockade of all three tachykinin receptors attenuates peristalsis without simultaneous depression of cholinergic transmission.
31. Krysiak P.S., Preiksaitis H.G. Tachykinins contribute to nerve-mediated contractions in the human esophagus. Gastroenterology. 120:2001;39-48.
32. 2 receptor activation is greatly reduced in colon muscle strips from patients with inflammatory bowel disease.
33. 3 receptor agonists.
34. Barthó L., Lénárd L., Patacchini R., Halmai V., Wilhelm M., Holzer P., Maggi C.A. Tachykinin receptors are involved in the 'local efferent' motor response to capsaicin in the guinea-pig small intestine and oesophagus. Neuroscience. 90:1999;221-228.
35. 2 receptors are involved in the neural pathways that govern the formation of migrating motor complexes in the mouse colon.
36. Frieling T., Dobreva G., Weber E., Becker K., Rupprecht C., Neunlist M., Schemann M. Different tachykinin receptors mediate chloride secretion in the distal colon through activation of submucosal neurones. Naunyn Schmiedebergs Arch Pharmacol. 359:1999;71-79.
37. Goldhill J., Porquet M.F., Selve N. Antisecretory and relaxatory effects of tachykinin antagonists in the guinea-pig intestinal tract. J Pharm Pharmacol. 51:1999;1041-1048.
38. 1 receptor antagonist SR-140333.
39. 2 receptor mediates contraction and ion transport in rat colon by different mechanisms. Eur J Pharmacol. 415:2001;277-283.
40. Riegler M., Castagliuolo I., So P.T., Lotz M., Wang C., Wlk M., Sogukoglu T., Cosentini E., Bischof G., Hamilton G., et al. Effects of substance P on human colonic mucosa in vitro. Am J Physiol. 276:1999;G1473-G1483.
41. Schmidt P.T., Rasmussen T.N., Holst J.J. Tachykinins stimulate acid and pepsinogen secretion in the isolated porcine stomach. Acta Physiol Scand. 166:1999;335-340.
42. Schmidt P.T., Tornoe K., Poulsen S.S., Rasmussen T.N., Holst J.J. Tachykinins in the porcine pancreas: potent exocrine and endocrine effects via NK-1 receptors. Pancreas. 20:2000;241-247.
43. Kirkwood K.S., Kim E.H., He X.D., Calaustro E.Q., Domush C., Yoshimi S.K., Grady E.F., Maa J., Bunnett N.W., Debas H.T. Substance P inhibits pancreatic exocrine secretion via a neural mechanism. Am J Physiol. 277:1999;G314-G320.
44. Rydning A., Lyng O., Aase S., Grønbech J.E. Substance P may attenuate gastric hyperemia by a mast cell-dependent mechanism in the damaged gastric mucosa. Am J Physiol. 277:1999;G1064-G1073.
45. Sturiale S., Barbara G., Qiu B., Figini M., Geppetti P., Gerard N., Gerard C., Grady E.F., Bunnett N.W., Collins S.M. Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P. Proc Natl Acad Sci USA. 96:1999;11653-11658.
46. Maa J., Grady E.F., Kim E.H., Yoshimi S.K., Hutter M.M., Bunnett N.W., Kirkwood K.S. NK-1 receptor desensitization and neutral endopeptidase terminate SP-induced pancreatic plasma extravasation. Am J Physiol. 279:2000;G726-G732. The effect of SP infusion to stimulate plasma protein extravasation is augmented by the neutral endopeptidase inhibitor phosphoramidon.
47. Evangelista S. Involvement of tachykinins in intestinal inflammation. Curr Pharm Des. 7:2001;19-30.
48. Maifrino L.B., Liberti E.A., de Souza R.R. Vasoactive-intestinal-peptide- and substance P-immunoreactive nerve fibres in the myenteric plexus of mouse colon during the chronic phase of Trypanosoma cruzi infection. Ann Trop Med Parasitol. 93:1999;49-56.
49. Depoortere I., Thijs T., Thielemans L., Keith J.C., van Assche G., Peeters T.L. Effect of recombinant human interleukin-11 on motilin and substance P release in normal and inflamed rabbits. Regul Pept. 97:2001;111-119.
50. Traub R.J., Hutchcroft K., Gebhart G.F. The peptide content of colonic afferents decreases following colonic inflammation. Peptides. 20:1999;267-273.
51. Forsgren S., Höckerfelt U., Norrgård Ö., Henriksson R., Franzén L. Pronounced substance P innervation in irradiation-induced enteropathy - a study on human colon. Regul Pept. 88:2000;1-13.
52. Di Sebastiano P., di Mola F.F., Di Febbo C., Baccante G., Porreca E., Innocenti P., Friess H., Büchler M.W. Expression of interleukin 8 (IL-8) and substance P in human chronic pancreatitis. Gut. 47:2000;423-428.
53. 1 receptor antagonist CP-96,345.
54. 1 receptor antagonist, in acute rectocolitis induced by acetic acid in guinea-pigs. Eur J Pharmacol. 374:1999;277-283.
55. 2 receptor antagonist nepadutant.
56. 1 receptor knockout abolishes the ability of SP to increase vascular permeability in the mouse pancreas and depresses the effect of caerulein to cause pancreatic plasma protein extravasation and myeloperoxidase accumulation.
57. Depoortere I., Thijs T., van Assche G., Keith J.C. Jr, Peeters T.L. Dose-dependent effects of recombinant human interleukin-11 on contractile properties in rabbit 2,4,6-trinitrobenzene sulfonic acid colitis. J Pharmacol Exp Ther. 294:2000;983-990.
58. Tomita R., Tanjoh K., Fujisaki S., Fukuzawa M. Peptidergic nerves in the colon of patients with ulcerative colitis. Hepatogastroenterology. 47:2000;400-404.
59. 2 receptors in gastric barosensitivity and in experimental ileus in rats. Neurogastroenterol Motil. 13:2001;45-53.
60. 2 receptors.
61. Gay J., Fioramonti J., Garcia-Villar R., Emonds-Alt X., Buéno L. Involvement of tachykinin receptors in sensitisation to cow's milk proteins in guinea pigs. Gut. 44:1999;497-503.
62. Buéno L., Fioramonti J., Garcia-Villar R. Pathobiology of visceral pain: molecular mechanisms and therapeutic implications. III. Visceral afferent pathways: a source of new therapeutic targets for abdominal pain. Am J Physiol. 278:2000;G670-G676.
63. 1 receptors play an essential role in neurogenic inflammatory processes within the colon, in the central transmission of chemical stimulation of the colon, and in the development of primary mechanical hyperalgesia in the colon and referred mechanical hyperalgesia in the abdominal skin.
64. Lee O.Y., Munakata J., Naliboff B.D., Chang L., Mayer E.A. A double blind parallel group pilot study of the effects of CJ-11,974 and placebo on perceptual and emotional responses to rectosigmoid distension in IBS patients [abstract]. Gastroenterology. 118:2000;A846.
65. Julia V., Su X., Buéno L., Gebhart G.F. Role of neurokinin 3 receptors on responses to colorectal distention in the rat: electrophysiological and behavioral studies. Gastroenterology. 116:1999;1124-1131.
66. 2 receptor antagonist.
67. 2 receptors, but not by separate blockade of any of these receptors.